His primary areas of investigation include Parkinson's disease, Subthalamic nucleus, Deep brain stimulation, Neuroscience and Central nervous system disease. His Parkinson's disease study combines topics from a wide range of disciplines, such as Physical therapy and Surgery. His biological study spans a wide range of topics, including Cognition, Neuropsychology, Anatomy, Stimulation and Cognitive decline.
His Deep brain stimulation research includes themes of Gait, Physical medicine and rehabilitation, Slow-wave sleep and Dysmetria, Ataxia. Leonardo Lopiano studied Internal medicine and Endocrinology that intersect with Analgesic. His work deals with themes such as Nocebo Effect, Placebo, Nocebo and Psychiatry, Anxiety, which intersect with Disease.
Leonardo Lopiano focuses on Parkinson's disease, Deep brain stimulation, Internal medicine, Disease and Subthalamic nucleus. His biological study focuses on Levodopa. The study incorporates disciplines such as Neuropsychology, Audiology, Rating scale, Psychiatry and Beck Depression Inventory in addition to Deep brain stimulation.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Endocrinology. Leonardo Lopiano combines subjects such as Bioinformatics, Anxiety, Placebo, Physical therapy and Depression with his study of Disease. His Subthalamic nucleus research is multidisciplinary, incorporating perspectives in Gait analysis and Central nervous system disease.
His main research concerns Parkinson's disease, Internal medicine, Neurology, Disease and Deep brain stimulation. His studies deal with areas such as Quality of life, Physical medicine and rehabilitation and Activities of daily living as well as Parkinson's disease. The various areas that he examines in his Internal medicine study include Gastroenterology and Rating scale.
His Neurology research incorporates elements of Neurosurgery, Pediatrics and Neuropsychology. Leonardo Lopiano usually deals with Disease and limits it to topics linked to Depression and Anxiety. His research in Deep brain stimulation is mostly concerned with Subthalamic nucleus.
The scientist’s investigation covers issues in Parkinson's disease, Internal medicine, Disease, Neurology and Levodopa. His research integrates issues of Physical therapy and Neuroscience in his study of Parkinson's disease. His Disease study integrates concerns from other disciplines, such as Ambulatory blood pressure, Cognition, Oncology and Cardiology.
His work focuses on many connections between Neurology and other disciplines, such as Quality of life, that overlap with his field of interest in Cohort. His research in Levodopa intersects with topics in Anesthesia, Vitamin B12, Methylmalonic acid, Gastroenterology and Deep brain stimulation. Leonardo Lopiano has researched Deep brain stimulation in several fields, including Meta-analysis, LRRK2, Camptocormia and Rating scale.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses
Fabrizio Benedetti;Antonella Pollo;Leonardo Lopiano;Michele Lanotte.
The Journal of Neuroscience (2003)
WHEN WORDS ARE PAINFUL: UNRAVELING THE MECHANISMS OF THE NOCEBO EFFECT
Fabrizio Benedetti;Michele Maria Rosario Lanotte;Leonardo Lopiano;L. Colloca.
Neuroscience (2007)
Overt versus covert treatment for pain, anxiety, and Parkinson's disease
Luana Colloca;Leonardo Lopiano;Michele Lanotte;Fabrizio Benedetti.
Lancet Neurology (2004)
Early-onset parkinsonism associated with PINK1 mutations Frequency, genotypes, and phenotypes
V. Bonifati;C. F. Rohé;G. J. Breedveld;E. Fabrizio.
Neurology (2005)
Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus.
Fabrizio Benedetti;Luana Colloca;Elena Torre;Michele Lanotte.
Nature Neuroscience (2004)
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
A. Di Fonzo;H. F. Chien;M. Socal;S. Giraudo.
Neurology (2007)
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters.
M Rizzone;M Lanotte;B Bergamasco;A Tavella.
Journal of Neurology, Neurosurgery, and Psychiatry (2001)
Open versus hidden medical treatments: The patient's knowledge about a therapy affects the therapy outcome.
Fabrizio Benedetti;Giuliano Maggi;Leonardo Lopiano;Michele Maria Rosario Lanotte.
Prevention & Treatment (2003)
Proteome analysis of human substantia nigra in Parkinson's disease
Manuela Basso;Sabrina Giraudo;Davide Corpillo;Bruno Bergamasco.
Proteomics (2004)
Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation
M M Lanotte;M Rizzone;B Bergamasco;G Faccani.
Journal of Neurology, Neurosurgery, and Psychiatry (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Padua
Brighton and Sussex Medical School
University of Verona
University of Salerno
Krembil Research Institute
University of Turin
Catholic University of America
University of Brescia
University of Chieti-Pescara
University of Pisa
University of Chicago
Vanderbilt University
Memorial University of Newfoundland
Freie Universität Berlin
Teagasc - The Irish Agriculture and Food Development Authority
Université Paris Cité
Universität Hamburg
Harvard University
National Institutes of Health
University of Pittsburgh
Leiden University
University of Chicago
Southern Medical University
Duke University
Ghent University
Max Planck Society